lobbying_filings_raw: 7c27bbf3-e77d-4ed0-b064-282b2afe84f4

Raw lobbying disclosure filings from the Senate Office of Public Records (SOPR). Each row is a single filing — registrations, quarterly reports, amendments, and terminations. Includes registrant and client names, reported income/expenses, filing period, and the full raw JSON from the API.

This data as json

filing_uuid filing_type registrant_id registrant_name client_id client_name filing_year filing_period received_date amount_reported is_amendment is_no_activity is_termination raw_json registrant_state registrant_country registrant_house_id client_state client_ppb_state client_country client_ppb_country client_general_description client_government_entity affiliated_org_count client_entity_id client_government_unit_id client_match_method client_match_confidence
7c27bbf3-e77d-4ed0-b064-282b2afe84f4 Q3 23645 MANATT, PHELPS, AND PHILLIPS 130873 NEKTAR THERAPEUTICS 2018 third_quarter 2018-10-16T10:28:41.107000-04:00 108000.0 0 0 0 {"url": "https://lda.senate.gov/api/v1/filings/7c27bbf3-e77d-4ed0-b064-282b2afe84f4/", "filing_uuid": "7c27bbf3-e77d-4ed0-b064-282b2afe84f4", "filing_type": "Q3", "filing_type_display": "3rd Quarter - Report", "filing_year": 2018, "filing_period": "third_quarter", "filing_period_display": "3rd Quarter (July 1 - Sep 30)", "filing_document_url": "https://lda.senate.gov/filings/public/filing/7c27bbf3-e77d-4ed0-b064-282b2afe84f4/print/", "filing_document_content_type": "text/html", "income": "108000.00", "expenses": null, "expenses_method": null, "expenses_method_display": null, "posted_by_name": "Jack Quinn", "dt_posted": "2018-10-16T10:28:41.107000-04:00", "termination_date": null, "registrant_country": "United States of America", "registrant_ppb_country": null, "registrant_address_1": "1050 Connecticut Ave NW", "registrant_address_2": "Suite 600", "registrant_different_address": false, "registrant_city": "Washington", "registrant_state": "DC", "registrant_zip": "20036", "registrant": {"id": 23645, "url": "https://lda.senate.gov/api/v1/registrants/23645/", "house_registrant_id": 30207, "name": "MANATT, PHELPS, AND PHILLIPS", "description": "Law firm", "address_1": "1050 Connecticut Ave NW", "address_2": "Suite 600", "address_3": null, "address_4": null, "city": "Washington", "state": "DC", "state_display": "District of Columbia", "zip": "20036", "country": "US", "country_display": "United States of America", "ppb_country": "US", "ppb_country_display": "United States of America", "contact_name": "JUNE DEHART", "contact_telephone": "+1 202-585-6500", "dt_updated": "2026-01-27T09:50:31.744593-05:00"}, "client": {"id": 130873, "url": "https://lda.senate.gov/api/v1/clients/130873/", "client_id": 1004090, "name": "NEKTAR THERAPEUTICS", "general_description": "biopharmaceutical company", "client_government_entity": false, "client_self_select": null, "state": "CA", "state_display": "California", "country": "US", "country_display": "United States of America", "ppb_state": "CA", "ppb_state_display": "California", "ppb_country": "US", "ppb_country_display": "United States of America", "effective_date": "2017-09-19"}, "lobbying_activities": [{"general_issue_code": "PHA", "general_issue_code_display": "Pharmacy", "description": "FDA oversight of certain pain reliever products", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 66872, "prefix": null, "prefix_display": null, "first_name": "JACK", "nickname": null, "middle_name": null, "last_name": "QUINN", "suffix": null, "suffix_display": null}, "covered_position": "Dep. COS and Counselor to the Vice President, COS to the VP and Assistant to President, Counsel to the President", "new": false}], "government_entities": [{"id": 135, "name": "Food & Drug Administration (FDA)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}], "conviction_disclosures": [], "foreign_entities": [], "affiliated_organizations": []} DC US 30207 CA CA US US biopharmaceutical company 0 0 1357   normalized_name 0.7

Links from other tables